Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • clinical
  • Published:

Disparities in Hispanic/Latino and non-Hispanic Black men with low-risk prostate cancer and eligible for active surveillance: a population-based study

Abstract

Background

Non-Hispanic Black (NHB) men are at an increased risk for aggressive prostate cancer (PCa), making active surveillance (AS) potentially less optimal in this population. This concern has not been explored in other minority populations—specifically, Hispanic/Latino men. We recently found that Mexican-American men demonstrate an increased risk of PCa-specific mortality, and we hypothesized that they may also be at risk for an adverse outcome on AS.

Methods

Using the Surveillance, Epidemiology, and End Results (SEER) program, we extracted a population-based cohort of men diagnosed from 2004 to 2013 with localized or regional PCa, who had ≤2 cores of only Grade Group (GG) 1 cancer, and underwent radical prostatectomy (RP) with available biopsy and surgical pathology results. We measured discovery of high-risk PCa at RP and collected socioeconomic status (SES) data across different racial/ethnic groups. We defined aggressive tumors as either an upgrade to GG 3 or higher (GG3+) cancer or non-organ-confined disease (≥pT3a or N1). Univariate and multivariate logistic regression models were developed to assess the association between racial/ethnic categories and the previously mentioned adverse oncologic outcomes both with and without adjusting for SES factors.

Results

NHB and Mexican-American men were significantly more likely to have aggressive PCa, following RP. In multivariable logistic regression adjusting for SES factors and relative to non-Hispanic White (NHW) men, Mexican-American men had at increased odds of upgrading to GG3+ (OR 1.67; 95% CI [1.00–2.90]). NHB men were more likely to have non-organ-confined disease (OR 1.34; 95% CI [1.06–1.69]), while Mexican-American men had a similar risk to NHW men.

Conclusion

Among individuals with low-risk PCa and eligible for AS, Mexican-American and NHB men are at an increased risk of harboring more aggressive disease at RP. This novel finding among Mexican-Americans deserves further evaluation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1

Similar content being viewed by others

References

  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30.

    Article  Google Scholar 

  2. Oakley-Girvan I, Kolonel LN, Gallagher RP, Wu AH, Felberg A, Whittemore AS. Stage at diagnosis and survival in a multiethnic cohort of prostate cancer patients. Am J Public Health. 2003;93:1753–9.

    Article  Google Scholar 

  3. Iremashvili V, Soloway MS, Rosenberg DL, Manoharan M. Clinical and demographic characteristics associated with prostate cancer progression in patients on active surveillance. J Urol. 2012;187:1594–1600.

    Article  Google Scholar 

  4. Sundi D, Ross AE, Humphreys EB, Han M, Partin AW, Carter HB, et al. African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them? J Clin Oncol. 2013;31:2991–7.

    Article  Google Scholar 

  5. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), Washington, DC: NCCN; 2018.

  6. Motel S, Patten E. Statistical portrait of Hispanics in the United States, 2011. Washington, DC: Pew Hispanic Center; 2013.

  7. Conomos MP, Laurie CA, Stilp AM, Gogarten SM, McHugh CP, Nelson SC, et al. Genetic diversity and association studies in US Hispanic/Latino populations: applications in the Hispanic Community Health Study/Study of Latinos. Am J Hum Genet. 2016;98:165–84.

    Article  CAS  Google Scholar 

  8. Browning SR, Grinde K, Plantinga A, Gogarten SM, Stilp AM, Kaplan RC, et al. Local ancestry inference in a large US-based Hispanic/Latino study: Hispanic Community Health Study/Study of Latinos (HCHS/SOL). G3 (Bethesda). 2016;6:1525–34.

    Article  Google Scholar 

  9. Stern MC, Fejerman L, Das R, Setiawan WV, Cruz-Correa MR, Perez-Stable EJ, et al. Variability in cancer risk and outcomes within US Latinos by National Origin and Genetic Ancestry. Cancer Epidemiol Rep. 2016;3:181–90.

    Article  Google Scholar 

  10. Motel S, Patten E. The 10 largest Hispanic origin groups: characteristics, rankings, top counties/Source: Pew Hispanic Center tabulations of the 2010 ACS. Hispanic trends. Washington, DC: Pew Research Center; 2012.

  11. Young R. Race/ethnicity. AMA manual of style: a guide for authors and editors, 10th edn. Oxford: Oxford University Press; 2007.

    Book  Google Scholar 

  12. Krieger N, Quesenberry C Jr, Peng T, Horn-Ross P, Stewart S, Brown S, et al. Social class, race/ethnicity, and incidence of breast, cervix, colon, lung, and prostate cancer among Asian, Black, Hispanic, and White residents of the San Francisco Bay Area, 1988–92 (United States). Cancer Causes Control. 1999;10:525–37.

    Article  CAS  Google Scholar 

  13. Hoffman RM, Gilliland FD, Eley JW, Harlan LC, Stephenson RA, Stanford JL, et al. Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study. J Natl Cancer Inst. 2001;93:388–95.

    Article  CAS  Google Scholar 

  14. Shavers VL, Brown M, Klabunde CN, Potosky AL, Davis W, Moul J, et al. Race/ethnicity and the intensity of medical monitoring under ‘watchful waiting’for prostate cancer. Med Care. 2004;42:239–50.

    Article  Google Scholar 

  15. Clegg LX, Li FP, Hankey BF, Chu K, Edwards BK. Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study. Arch Intern Med. 2002;162:1985–93.

    Article  Google Scholar 

  16. Chinea FM, Patel VN, Kwon D, Lamichhane N, Lopez C, Punnen S, Kobetz EN, Abramowitz MC, Pollack A. Ethnic heterogeneity and prostate cancer mortality in Hispanic/Latino men: a population-based study. Oncotarget. 8.41 (2017): 69709.

  17. National Institute of Cancer. Number of Persons by Race and Hispanic Ethnicity for SEER Participants. https://seer.cancer.gov/registries/data.html (accessed December 17, 2017).

  18. Yu M, Tatalovich Z, Gibson JT, Cronin KA. Using a composite index of socioeconomic status to investigate health disparities while protecting the confidentiality of cancer registry data. Cancer Causes Control. 2014;25:81–92.

    Article  Google Scholar 

  19. Krieger N, Chen JT, Waterman PD, Soobader M-J, Subramanian SV, Carson R. Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter?: the Public Health Disparities Geocoding Project. Am J Epidemiol. 2002;156:471–82.

    Article  Google Scholar 

  20. National Institute of Cancer. PSA Values and SEER Data. Updated April 14, 2017. https://seer.cancer.gov/data/psa-values.html (accessed December 17, 2017).

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sanoj Punnen.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Katz, J.E., Chinea, F.M., Patel, V.N. et al. Disparities in Hispanic/Latino and non-Hispanic Black men with low-risk prostate cancer and eligible for active surveillance: a population-based study. Prostate Cancer Prostatic Dis 21, 533–538 (2018). https://doi.org/10.1038/s41391-018-0057-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41391-018-0057-6

This article is cited by

Search

Quick links